Hyseq Inc.
Biopharmaceutical company

Annual Report
Investor Kit

Hyseq Inc. applies its proprietary genomics platform to find and develop biopharmaceuticals for the treatment of disease.

The 1999 Annual Report design helped define Hyseq’s transition from a specialist in DNA sequencing and gene discovery, to a biopharmaceutical company. Through its clear, accessible design and interpretive graphics, the report explained the complexities of the genomics technology and how the discovery of rarely expressed genes can result in the development of new medical therapies.

A complementary custom investor marketing kit was also developed which included a folder graphically coordinated to the annual report design, press releases, and company fact sheets.